164 related articles for article (PubMed ID: 6467512)
1. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the fatty acid composition of erythrocyte and platelet membranes after diet therapy in patients with hyperlipoproteinemia type II].
Korf II; Meshcheriakova VA; Samsonov MA; Chepurnenko NV; Koshechkin VA
Vopr Med Khim; 1987; 33(3):73-7. PubMed ID: 3630021
[TBL] [Abstract][Full Text] [Related]
3. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
4. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
De Castro J; Hernández-Hernández A; Rodríguez MC; Sardina JL; Llanillo M; Sánchez-Yagüe J
Platelets; 2007 Feb; 18(1):43-51. PubMed ID: 17365853
[TBL] [Abstract][Full Text] [Related]
5. [Membrane platelet fatty acids: biochemical characterisation of the ischemic cardiovascular disease, characteristics of the paediatric age, through an artificial neural network interpretation].
Cocchi M; Tonello L; Cappello G; Tarozzi G; Nabacino L; Pastorini E; Bucciarelli S; Solazzo L; De Luca M; Visci G; Caramia G
Pediatr Med Chir; 2008; 30(1):25-30. PubMed ID: 18491675
[TBL] [Abstract][Full Text] [Related]
6. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
7. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
8. Comparison of changes in erythrocyte and platelet fatty acid composition and protein oxidation in advanced non-small cell lung cancer.
de Castro J; Hernández-Hernández A; Rodríguez MC; Llanillo M; Sánchez-Yagüe J
Cancer Invest; 2006; 24(4):339-45. PubMed ID: 16777684
[TBL] [Abstract][Full Text] [Related]
9. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
[TBL] [Abstract][Full Text] [Related]
10. Some aspects of platelet glucose metabolism in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Armani U; Piana A
Thromb Res; 1984 May; 34(3):233-9. PubMed ID: 6729778
[TBL] [Abstract][Full Text] [Related]
11. Possible relationship between altered fatty acid composition of serum, platelets, and aorta and hypertension induced by sugar feeding in rats.
El Hafidi M; Valdez R; Baños G
Clin Exp Hypertens; 2000 Jan; 22(1):99-108. PubMed ID: 10685728
[TBL] [Abstract][Full Text] [Related]
12. Relationships between serum lipids, platelet membrane fatty acid composition and platelet aggregation in type 2 diabetes mellitus.
Rodier M; Colette C; Crastes de Paulet P; Crastes de Paulet A; Monnier L
Diabete Metab; 1993; 19(6):560-5. PubMed ID: 8026607
[TBL] [Abstract][Full Text] [Related]
13. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
[No Abstract] [Full Text] [Related]
14. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
[TBL] [Abstract][Full Text] [Related]
15. [The effect of changes in the lipid composition of membranes on the functional activity of platelets].
Ishankhodzhaev TM; Bornikov VT; Zaĭnutdinov BR; Saatov TS
Biokhimiia; 1990 Aug; 55(8):1507-12. PubMed ID: 2288990
[TBL] [Abstract][Full Text] [Related]
16. [Changes in fatty acid composition of the plasma and erythrocytes in osteochondrosis].
Korf II; Tsagikian TA; Meshcheriakova VA; Levachev MM; Arutiunova MB
Vopr Med Khim; 1989; 35(4):81-4. PubMed ID: 2815685
[TBL] [Abstract][Full Text] [Related]
17. [Blood platelet changes in myeloproliferative disorders].
D'Angelo G; Calvano D; Giardini C
Minerva Med; 1988 Oct; 79(10):853-7. PubMed ID: 3141845
[TBL] [Abstract][Full Text] [Related]
18. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
Breuer JH; Harsányi V; Solti V; Hollán SR
Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
[TBL] [Abstract][Full Text] [Related]
19. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
Zucker S; Mielke CH
J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
[No Abstract] [Full Text] [Related]
20. Influence of some plasma fatty acids on the phospholipid fatty acid pattern of human platelets--an "ex vivo" experience.
Vallés J; Aznar J; Santos MT
Thromb Haemost; 1984 Dec; 52(3):232-5. PubMed ID: 6531750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
